Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to Companies who have applied for FDA Drug Approval
FDA Drug Approval Applications Sponsored by PADDOCK LLC
Application Number
Drugs/Products
Application Type
Most Recent Label Available Flag
Current Patent Flag
Action Type
Chemical Type
Ther Potential
Orphan Code
018200
MIDAMOR
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
040028
KIONEX
Abbreviated New Drug Application
Approval
040029
KIONEX
Abbreviated New Drug Application
Approval
040246
COMPRO
Abbreviated New Drug Application
Approval
040475
DIHYDROERGOTAMINE MESYLATE
Abbreviated New Drug Application
Approval
040530
TESTOSTERONE CYPIONATE
Abbreviated New Drug Application
Approval
040575
TESTOSTERONE ENANTHATE
Abbreviated New Drug Application
Approval
050610
ERYTHROMYCIN
New Drug Application
Approval
New manufacturer
(S) Standard review drug
062455
POLYMYXIN B SULFATE
Abbreviated New Drug Application
Approval
062456
BACITRACIN
Abbreviated New Drug Application
Approval
062613
NYSTATIN
Abbreviated New Drug Application
Approval
062687
ERYTHRA-DERM
Abbreviated New Drug Application
Approval
063329
CLINDA-DERM
Abbreviated New Drug Application
Approval
064118
NYSTOP
Abbreviated New Drug Application
Approval
065177
COLISTIMETHATE SODIUM
Abbreviated New Drug Application
Approval
075172
COLOCORT
Abbreviated New Drug Application
Approval
075600
PODOFILOX
Abbreviated New Drug Application
Approval
075988
PREDNISOLONE SODIUM PHOSPHATE
Abbreviated New Drug Application
Approval
076379
MIDAZOLAM HYDROCHLORIDE
Abbreviated New Drug Application
Approval
076763
CLOTRIMAZOLE
Abbreviated New Drug Application
Approval
076831
FLAVOXATE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
077536
MOEXIPRIL HYDROCHLORIDE
Abbreviated New Drug Application
Approval
077646
BROMOCRIPTINE MESYLATE
Abbreviated New Drug Application
Approval
077893
POLYETHYLENE GLYCOL 3350
Abbreviated New Drug Application
Approval
078266
CICLOPIROX
Abbreviated New Drug Application
Approval
079232
LAX-LYTE WITH FLAVOR PACKS
Abbreviated New Drug Application
Approval
079244
LORAZEPAM
Abbreviated New Drug Application
Approval
088082
HYDROCORTISONE
Abbreviated New Drug Application
Approval
090096
MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Abbreviated New Drug Application
Approval
090567
POLYETHYLENE GLYCOL 3350
Abbreviated New Drug Application
Approval
090590
SODIUM POLYSTYRENE SULFONATE
Abbreviated New Drug Application
Approval
090712
POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES
Abbreviated New Drug Application
Approval
090769
CLENZ-LYTE
Abbreviated New Drug Application
Approval
090898
CLOBETASOL PROPIONATE
Abbreviated New Drug Application
Approval
091312
CALCIUM ACETATE
Abbreviated New Drug Application
Approval
091326
NARATRIPTAN
Abbreviated New Drug Application
Approval
091561
CALCIUM ACETATE
Abbreviated New Drug Application
Approval
091573
TROSPIUM CHLORIDE
Abbreviated New Drug Application
Approval
200185
POTASSIUM CHLORIDE
Abbreviated New Drug Application
Approval
200529
INDOMETHACIN
Abbreviated New Drug Application
Approval
201189
REPAGLINIDE
Abbreviated New Drug Application
Approval
201291
TROSPIUM CHLORIDE
Abbreviated New Drug Application
Approval
201574
MORPHINE SULFATE
Abbreviated New Drug Application
Approval
201941
BROMFENAC SODIUM
Abbreviated New Drug Application
Approval
202393
DICLOFENAC SODIUM
Abbreviated New Drug Application
Approval
202605
ACETAMINOPHEN
Abbreviated New Drug Application
Approval
204278
HYDROMORPHONE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
204627
HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
204658
HYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
205292
BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
Abbreviated New Drug Application
Approval
205993
POTASSIUM CHLORIDE
Abbreviated New Drug Application
Approval
Back to Companies who have applied for FDA Drug Approval